Semaglutide Use Linked to Erythromelalgia Remission - Summary - MDSpire

Semaglutide Use Linked to Erythromelalgia Remission

Case details diagnostic workup and rapid symptom resolution following GLP-1 receptor agonist initiation.

  • By

  • Kathryn Wighton

  • April 22, 2026

  • 4 min

Share

Objective:

To report a case of complete remission of erythromelalgia symptoms following treatment with semaglutide, highlighting its potential significance in treatment options.

Key Findings:
  • Complete remission of erythromelalgia symptoms was achieved after starting semaglutide, with symptoms resolving before significant weight loss.
  • The patient's BMI decreased from 33.9 kg/m² to 23.2 kg/m² over 15 months.
  • Normal nerve fiber density and absence of thermal allodynia argued against small-fiber neuropathy.
Interpretation:

The rapid resolution of symptoms suggests a pharmacologic effect of semaglutide rather than solely weight loss, indicating a need for further research into its mechanisms.

Limitations:
  • Causality cannot be established from a single case.
  • Retrospective assessment and absence of validated pain scoring.
  • Lack of continuous perfusion or temperature monitoring, emphasizing the uniqueness of this case.
Conclusion:

This case represents the first documented instance of erythromelalgia remission following GLP-1 receptor agonist therapy, warranting further investigation into their role in neurovascular pain syndromes and potential therapeutic applications.

Original Source(s)

Semaglutide Use Linked to Erythromelalgia Remission

  • by Kathryn Wighton

  • April 22, 2026

Related Content

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.

AOPT Plus Collagen May Ease Rosacea

Randomized trial suggests better short-term outcomes and lower recurrence at 24 weeks.

GLP-1 Agents May Reduce Psoriasis Severity

National Psoriasis Foundation review highlights limited evidence and potential metabolic links.